News Image

Rezolute to Participate in Upcoming Investor Conferences

Provided By GlobeNewswire

Last update: Aug 27, 2025

REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that management will participate in the following investor conferences:

Read more at globenewswire.com

REZOLUTE INC

NASDAQ:RZLT (10/13/2025, 8:00:02 PM)

Premarket: 8.09 +0.02 (+0.25%)

8.07

-0.2 (-2.42%)



Find more stocks in the Stock Screener

Follow ChartMill for more